Atıf İçin Kopyala
Saglam S., Aykan N. F., ŞAKAR B., GÜLLÜOĞLU M., Balik E., Karanlik H.
JOURNAL OF GASTROINTESTINAL ONCOLOGY, cilt.2, sa.1, ss.19-26, 2011 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
2
Sayı:
1
-
Basım Tarihi:
2011
-
Doi Numarası:
10.3978/j.issn.2078-6891.2010.030
-
Dergi Adı:
JOURNAL OF GASTROINTESTINAL ONCOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Emerging Sources Citation Index (ESCI), Scopus
-
Sayfa Sayıları:
ss.19-26
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Background: Best response rates have been achieved with three-drug regimens containing 5-FU in the treatment of advanced gastric cancer (AGC) and oral fluoropyrimidines are the best alternatives as substitutes for infusional 5-FU. This study aimed to evaluate the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) regimens in AGC outpatients.